Morpholino-type ring

Industry

CPC
C12N2310/3233

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N2310/00Structure or type of the nucleic acid

Current Industry

C12N2310/3233Morpholino-type ring

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Antisense antibacterial compounds and methods
- Patent number 12,209,240
- Issue date Jan 28, 2025
- Board of Regents, The University of Texas System
- David Greenberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for reducing Ataxin-2 expression
- Patent number 12,188,020
- Issue date Jan 7, 2025
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Trimeric peptides for antisense delivery
- Patent number 12,168,059
- Issue date Dec 17, 2024
- Sarepta Therapeutics, Inc.
- Justin Wolfe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for the treatment of expanded repeat-assoc...
- Patent number 12,161,658
- Issue date Dec 10, 2024
- UNIVERSITY OF MASSACHUSETTS
- Joel D. Richter
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gapmer antisense oligonucleotides targeting SARS-CoV-2 for treating...
- Patent number 12,163,132
- Issue date Dec 10, 2024
- Children's National Medical Center
- Yi-Wen Chen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense oligonucleotides to restore dysferlin protein expression...
- Patent number 12,163,129
- Issue date Dec 10, 2024
- University of Massachusetts
- Robert H. Brown
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modulating the cellular stress response
- Patent number 12,157,888
- Issue date Dec 3, 2024
- The General Hospital Corporation
- Jeannie T. Lee
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment and diagnosis of inflammatory disorders
- Patent number 12,146,138
- Issue date Nov 19, 2024
- Zhenglun Zhu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Direct and selective inhibition of MDM4 for treatment of cancer
- Patent number 12,139,712
- Issue date Nov 12, 2024
- VIB VZW
- Jean-Christophe Marine
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense oligomers and methods of using the same for treating dise...
- Patent number 12,139,709
- Issue date Nov 12, 2024
- Sarepta Therapeutics, Inc.
- Frederick Joseph Schnell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modified antisense oligomers for exon inclusion in spinal muscular...
- Patent number 12,121,532
- Issue date Oct 22, 2024
- Sarepta Therapeutics, Inc.
- Marco A. Passini
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of treating cancer having an active Wnt/β-catenin pathway
- Patent number 12,109,212
- Issue date Oct 8, 2024
- Dana-Farber Cancer Institute, Inc.
- William C. Hahn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Polynucleotides containing a morpholino linker
- Patent number 12,071,620
- Issue date Aug 27, 2024
- ModernaTX, Inc.
- Gabor Butora
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-transferrin receptor antibody-PMO conjugates for inducing DMD...
- Patent number 12,071,621
- Issue date Aug 27, 2024
- AVIDITY BIOSCIENCES, INC.
- Beatrice Diana Darimont
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acid-polypeptide compositions and methods of inducing exon...
- Patent number 12,064,483
- Issue date Aug 20, 2024
- AVIDITY BIOSCIENCES, INC.
- Arthur A. Levin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for inhibiting detoxification response
- Patent number 12,065,648
- Issue date Aug 20, 2024
- The General Hospital Corporation
- Gary Ruvkun
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense nucleic acids
- Patent number 12,060,556
- Issue date Aug 13, 2024
- Nippon Shinyaku Co., Ltd.
- Naoki Watanabe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for reducing pathogenic isoforms
- Patent number 12,043,832
- Issue date Jul 23, 2024
- Washington University
- Andrew Findlay
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antisense compounds targeting genes associated with cystic fibrosis
- Patent number 12,042,508
- Issue date Jul 23, 2024
- Rosalind Franklin University of Medicine and Science
- Michelle L. Hastings
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Muscle targeting complexes and uses thereof for treating dystrophin...
- Patent number 12,005,124
- Issue date Jun 11, 2024
- Dyne Therapeutics, Inc.
- Romesh R. Subramanian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antisense nucleic acids
- Patent number 11,981,894
- Issue date May 14, 2024
- Nippon Shinyaku Co., Ltd.
- Yukiko Enya
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antisense oligonucleotide and composition for prevention or treatme...
- Patent number 11,963,974
- Issue date Apr 23, 2024
- National Center for Child Health and Development
- Go Tajima
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense oligonucleotides targeting SCN2A for the treatment of SCN...
- Patent number 11,939,582
- Issue date Mar 26, 2024
- RogCon, Inc.
- Steven Petrou
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Exon skipping compositions for treating muscular dystrophy
- Patent number 11,932,851
- Issue date Mar 19, 2024
- Sarepta Therapeutics, Inc.
- Richard K. Bestwick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antisense-induced exon exclusion in type VII collagen
- Patent number 11,911,403
- Issue date Feb 27, 2024
- Sarepta Therapeutics, Inc.
- Dan V. Mourich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for the specific inhibition of alpha-1 ant...
- Patent number 11,912,996
- Issue date Feb 27, 2024
- Dicerna Pharmaceuticals, Inc.
- Bob Dale Brown
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Agents useful in treating facioscapulohumeral muscular dystrophy
- Patent number 11,898,143
- Issue date Feb 13, 2024
- Université de Mons
- Alexandra Belayew
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Transcriptome in vivo analysis (TIVA) and transcriptome in situ ana...
- Patent number 11,873,312
- Issue date Jan 16, 2024
- The Trustees of the University of Pennsylvania
- James Eberwine
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Grant
Antiviral agents
- Patent number 11,866,706
- Issue date Jan 9, 2024
- Meharry Medical College
- Donald J. Alcendor
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Splice-switching oligonucleotides and methods of use
- Patent number 11,866,689
- Issue date Jan 9, 2024
- Duke University
- Jennifer Freedman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS FOR MODULATING mRNA SPLICING
- Publication number 20250051780
- Publication date Feb 13, 2025
- Entrada Therapeutics, Inc.
- Ziqing QIAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR MODULATING INTERFERON REGULATORY FACTO...
- Publication number 20250051393
- Publication date Feb 13, 2025
- Entrada Therapeutics, Inc.
- Ziqing QIAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Antisense Compounds Targeting Genes Associated with Cystic Fibrosis
- Publication number 20250049838
- Publication date Feb 13, 2025
- ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE
- Michelle L. Hastings
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
COMPOSITIONS COMPRISING THERAPEUTIC NUCLEIC ACID AND SAPONIN FOR TH...
- Publication number 20250051770
- Publication date Feb 13, 2025
- Sapreme Technologies B.V.
- Miriam Verena BUJNY
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROCESSES FOR PREPARING PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS VIA...
- Publication number 20250043283
- Publication date Feb 6, 2025
- Sarepta Therapeutics, Inc.
- Kyle A. Totaro
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR INHIBITING DETOXIFICATION RESPONSE
- Publication number 20250043286
- Publication date Feb 6, 2025
- The General Hospital Corporation
- Gary Ruvkun
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDES FOR SNCA MODULATION
- Publication number 20250043284
- Publication date Feb 6, 2025
- University of Massachusetts
- Anastasia Khvorova
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
STAGGERED TRIPLE LIPID-MODIFIED NUCLEIC ACID COMPOUNDS
- Publication number 20250027082
- Publication date Jan 23, 2025
- Novartis AG
- Charles ALLERSON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DOSING OF MUSCLE TARGETING COMPLEXES FOR TREATING DYSTROPHINOPATHIES
- Publication number 20250018050
- Publication date Jan 16, 2025
- Dyne Therapeutics, Inc.
- Cody A. Desjardins
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NEURODEGENERATIVE DISORDERS
- Publication number 20250011772
- Publication date Jan 9, 2025
- Teesside University
- Pavlos Alifragis
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DELIVERY OF ANITSENSE OLIGOMERS BY MIRROR IMAGE PEPTIDES
- Publication number 20250011777
- Publication date Jan 9, 2025
- Sarepta Therapeutics, Inc.
- Carly K. SCHISSEL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE COMPOUNDS AND METHODS FOR TARGETING CUG REPEATS
- Publication number 20250011774
- Publication date Jan 9, 2025
- Entrada Therapeutics, Inc.
- Xiulong SHEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD OF TREATMENT FOR OPTIC ATROPHY
- Publication number 20250002917
- Publication date Jan 2, 2025
- PYC Therapeutics Limited
- Janya Grainok
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Means and Methods for Chronic Wound Healing
- Publication number 20240425857
- Publication date Dec 26, 2024
- VIB VZW
- Kodimangalam Ravichandran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR SKIPPING EXON 45 IN DUCHENNE MUSCULAR...
- Publication number 20240417429
- Publication date Dec 19, 2024
- Entrada Therapeutics, Inc.
- Xiang Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTISENSE-INDUCED EXON EXCLUSION IN TYPE VII COLLAGEN
- Publication number 20240415857
- Publication date Dec 19, 2024
- Sarepta Therapeutics, Inc.
- Dan V. Mourich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
- Publication number 20240401037
- Publication date Dec 5, 2024
- Universite de Mons
- Alexandra Belayew
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATING CANCER HAVING AN ACTIVE WNT/BETA-CATENIN PATHWAY
- Publication number 20240398804
- Publication date Dec 5, 2024
- Dana-Farber Cancer Institute, Inc.
- William C. HAHN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE-DRUG CONJUGATE
- Publication number 20240390508
- Publication date Nov 28, 2024
- Takeda Pharmaceutical Company Limited
- Takatoshi YOGO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHIN...
- Publication number 20240382609
- Publication date Nov 21, 2024
- Dyne Therapeutics, Inc.
- Cody A. Desjardins
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-TRANSFERRIN RECEPTOR ANTIBODY-PMO CONJUGATES FOR INDUCING DMD...
- Publication number 20240368598
- Publication date Nov 7, 2024
- Avidity Biosciences, Inc.
- Beatrice Diana DARIMONT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHIN...
- Publication number 20240368296
- Publication date Nov 7, 2024
- Dyne Therapeutics, Inc.
- Cody A. Desjardins
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Antisense Nucleic Acids
- Publication number 20240368597
- Publication date Nov 7, 2024
- NIPPON SHINYAKU CO., LTD.
- Yukiko ENYA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND MEANS FOR EFFICIENT SKIPPING OF AT LEAST ONE OF THE FOL...
- Publication number 20240360452
- Publication date Oct 31, 2024
- BioMarin Technologies B.V.
- Judith Christina Theodora Van Deutekom
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND METHODS OF INDUCING EXON...
- Publication number 20240358736
- Publication date Oct 31, 2024
- Avidity Biosciences, Inc.
- Arthur A. LEVIN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY
- Publication number 20240344067
- Publication date Oct 17, 2024
- Sarepta Therapeutics, Inc.
- Frederick Joseph SCHNELL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TRE...
- Publication number 20240327844
- Publication date Oct 3, 2024
- The University of Chicago
- Elizabeth McNally
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
STRUCTURE-BASED DESIGN OF ANTISENSE OLIGONUCLEOTIDE DRUGS
- Publication number 20240327449
- Publication date Oct 3, 2024
- The Regents of the University of California
- Feng Guo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHIN...
- Publication number 20240318176
- Publication date Sep 26, 2024
- Dyne Therapeutics, Inc.
- Cody A. Desjardins
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHIN...
- Publication number 20240318177
- Publication date Sep 26, 2024
- Dyne Therapeutics, Inc.
- Cody A. Desjardins
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Morpholino-type ring

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Antisense antibacterial compounds and methods

Methods for reducing Ataxin-2 expression

Trimeric peptides for antisense delivery

Compositions and methods for the treatment of expanded repeat-assoc...

Gapmer antisense oligonucleotides targeting SARS-CoV-2 for treating...

Antisense oligonucleotides to restore dysferlin protein expression...

Modulating the cellular stress response

Treatment and diagnosis of inflammatory disorders

Direct and selective inhibition of MDM4 for treatment of cancer

Antisense oligomers and methods of using the same for treating dise...

Modified antisense oligomers for exon inclusion in spinal muscular...

Methods of treating cancer having an active Wnt/β-catenin pathway

Polynucleotides containing a morpholino linker

Anti-transferrin receptor antibody-PMO conjugates for inducing DMD...

Nucleic acid-polypeptide compositions and methods of inducing exon...

Methods and compositions for inhibiting detoxification response

Antisense nucleic acids

Methods and compositions for reducing pathogenic isoforms

Antisense compounds targeting genes associated with cystic fibrosis

Muscle targeting complexes and uses thereof for treating dystrophin...

Antisense nucleic acids

Antisense oligonucleotide and composition for prevention or treatme...

Antisense oligonucleotides targeting SCN2A for the treatment of SCN...

Exon skipping compositions for treating muscular dystrophy

Antisense-induced exon exclusion in type VII collagen

Methods and compositions for the specific inhibition of alpha-1 ant...

Agents useful in treating facioscapulohumeral muscular dystrophy

Transcriptome in vivo analysis (TIVA) and transcriptome in situ ana...

Antiviral agents

Splice-switching oligonucleotides and methods of use

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS FOR MODULATING mRNA SPLICING

COMPOSITIONS AND METHODS FOR MODULATING INTERFERON REGULATORY FACTO...

Antisense Compounds Targeting Genes Associated with Cystic Fibrosis

COMPOSITIONS COMPRISING THERAPEUTIC NUCLEIC ACID AND SAPONIN FOR TH...

PROCESSES FOR PREPARING PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS VIA...

METHODS AND COMPOSITIONS FOR INHIBITING DETOXIFICATION RESPONSE

OLIGONUCLEOTIDES FOR SNCA MODULATION

STAGGERED TRIPLE LIPID-MODIFIED NUCLEIC ACID COMPOUNDS

DOSING OF MUSCLE TARGETING COMPLEXES FOR TREATING DYSTROPHINOPATHIES

NEURODEGENERATIVE DISORDERS

DELIVERY OF ANITSENSE OLIGOMERS BY MIRROR IMAGE PEPTIDES

ANTISENSE COMPOUNDS AND METHODS FOR TARGETING CUG REPEATS

METHOD OF TREATMENT FOR OPTIC ATROPHY

Means and Methods for Chronic Wound Healing

COMPOSITIONS AND METHODS FOR SKIPPING EXON 45 IN DUCHENNE MUSCULAR...

ANTISENSE-INDUCED EXON EXCLUSION IN TYPE VII COLLAGEN

AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

METHODS OF TREATING CANCER HAVING AN ACTIVE WNT/BETA-CATENIN PATHWAY

HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE-DRUG CONJUGATE

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHIN...

ANTI-TRANSFERRIN RECEPTOR ANTIBODY-PMO CONJUGATES FOR INDUCING DMD...

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHIN...

Antisense Nucleic Acids

METHODS AND MEANS FOR EFFICIENT SKIPPING OF AT LEAST ONE OF THE FOL...

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND METHODS OF INDUCING EXON...

EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY

ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TRE...

STRUCTURE-BASED DESIGN OF ANTISENSE OLIGONUCLEOTIDE DRUGS

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHIN...

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHIN...